Tag: stem cell research

Blog Posts (17)

October 5, 2011

Happy Stem Cell [Awareness] Day!

There is a day for virtually everything these days. Forget the old school Valentine’s and Sweetest Day, or even Administrative Professional’s or Grandparents’ Day.…

February 4, 2011

Caplan Discusses Ghosts of Bioethics' Present, Past and Future

On Point of Inquiry, Art Caplan discusses how bioethics has “come of age” and what questions are likely to engage the field in the future.…

November 18, 2010

Moreno Delves Deeper into Bush and Kass' "Decision Points"

Fascinated by Bush’s moral reasoning when it came to his stem cell decision of August 9th, 2001, Jonathan Moreno delves even deeper into the passages of the former president’s autobiography to explore the faulty logic of his position regarding embryonic stem cell research.…

November 10, 2010

Glenn McGee Was Right: It was Leon Kass' "Decision Point"

For those of you who will not be reading former President George W. Bush’s autobiography, Decision Points (I am among them), the National Journal has pulled out some choice selections of those items that might not make the headlines.…

September 1, 2010

McGee: Back on the Embryonic Stem Cell Merry-Go-Round, But Going In A New Direction

On the Bioethics Channel, Dr. Glenn McGee, the John B. Francis Chair in Bioethics at the Center for Practical Bioethics, stakes out his own position regarding the recent U.S.…

August 25, 2010

Caplan: America's Sick Deserve Better

Many have called it legislating from the bench. Others have called it sending us back to the stone age. But as Arthur Caplan puts it in this week’s MSNBC column Judge Royce Lamberth’s ruling preventing the use of federal funding for embryonic stem cell research hasn’t just hobbled stem cell research–it has killed the hopes for recovery of tens of thousands if not millions of Americans.…

August 3, 2010

Geron Gets Green Light...Are the Floodgates Opening?

With the FDA approval of the first human stem cell trial from the Geron Corporation, there can be no doubt that dozens of other human clinical trials will quickly follow on its heels for approval for hESCs to be used in human beings to treat everything from spinal cord injuries to Alzheimer’s Disease to cancer.…

July 6, 2010

Therapeutic Misconception At Its Worst

The International Society for Stem Cell Research (ISSCR) has created a website that aims purportedly to help patients assess the claims made by stem cell companies and researchers offering cures via stem cell research.…

May 12, 2010

May Issue of AJOB: SPECIAL ISSUE ON STEM CELL TOURISM

Featuring paired issues by Stanford’s Charles E. Murdoch and Christopher Thomas Scott and University of Alberta’s Amy Zarzeczny and Timothy Caulfield, the May issue of AJOB addresses the hot topic of the ethics of stem cell tourism.…

October 21, 2009

Should Hwang Do Time in the Big House?

For the disgrace and shame he placed upon stem cell research in South Korea and for many stem cell research more generally, he should do some time in the slammer.…

View More Blog Entries

News (6)

November 14, 2012 3:50 pm

Stem Cell Finding Could Advance Immunotherapy for Lung Cancer (Science Daily)

A University of Cincinnati (UC) Cancer Institute lung cancer research team reports that lung cancer stem cells can be isolated — and then grown — in a preclinical model, offering a new avenue for investigating immunotherapy treatment options that specifically target stem cells.

June 1, 2012 8:58 am

Another Korean Stem Cell Study Scandal (First Things)

At the height of the great Embryonic Stem Cell Hype, Hwang Woo-suk fraudulently claimed to have created human cloned embryos and derived stem cells therefrom. He paid a price in reputation but not his freedom, despite obtaining research grants under false pretenses. Now, another Korean stem cell scientist stands accused of falsifying research reports.

May 31, 2012 11:43 am

Did the California stem cell program promise miracle cures? (Los Angeles Times)

You be the judge. Alan Trounson and Jonathan Thomas, the president and chairman of California’s stem cell program, have taken issue with how I characterized their program in a column this week. I pointed out that its founding 2004 initiative, Proposition 71, “was sold to a gullible public via candy-coated images of Christopher Reeve walking again and Michael J. Fox cured of Parkinson’s.”

May 14, 2012 11:14 am

Michigan lawmakers have no business meddling in stem cell research (AnnArbor.com)

If there was any serious question in Michigan whether stem cell research is a valuable and morally acceptable means of advancing medical science, it was resolved in 2008 when voters approved a constitutional amendment that allows researchers to create embryonic stem cell cultures and use them in medical research. The people of Michigan understood that embryos used in this form of research would be discarded otherwise, and the potential benefit to human health is too great to shut down such promising avenues of study. Unfortunately, there are lawmakers who would defy the will of the people by attacking stem cell research through backdoor means.

May 7, 2012 11:17 am

NY medical schools chart progress with stem cells (New York Times)

Almost halfway through a $600 million state program supporting stem cell research, eight medical schools around New York are reporting progress on projects such as replicating liver cells and eradicating leukemia cells. A new report from Associated Medical Schools of New York updates work at the institutions where hundreds of researchers are starting to unravel causes and potential treatments for conditions ranging from autism to heart disease and cancer.

May 2, 2012 11:14 am

South Korea steps up stem-cell work (Nature)

South Korea has been trying to restore its tarnished image in the field after the fall of one of its stellar stem-cell scientists, Woo Suk Hwang, who was convicted in 2009 for embezzlement and bioethics violations after falsifying results. The country has begun to regain confidence from a series of successful research projects, and is ranked in the world’s top ten for stem-cell and regenerative medicine research in terms of number and quality of publications. The South Korean government thinks that the country can be a top global competitor if the field is given enough support.